The Short-term Effect of ELTGOL on Pulmonary Ventilation Valued Through Electrical Impedance Tomography in Cystic Fibrosis Patients
The Short-term Effect of ELTGOL on Pulmonary Ventilation Valued Through Electrical Impedance Tomography in Cystic Fibrosis Patients
Cystic Fibrosis (CF) is the most common lethal autosomal recessive disease. Respiratory
 therapy is always recommended to the CF patient with pulmonary involvement and has differents
 techniques and devices, however, there is no consensus on the effectiveness of the techniques
 used, there is a need to determine the applicability of the therapeutic resources used.
 Therefore, the aim of the study is to determine the short-term effectiveness of ELTGOL on
 Average Electrical Impedance on the End of Expiration (MIEFE) pulmonary, assessed by
 Electrical Impedance Tomography (EIT) in individuals with CF through a clinical trial
 randomized crossover. Volunteers will be included with FC with moderate to severe lung
 disease with chest ≥ 74 cm that do not show: episode of pulmonary infectious exacerbations in
 the last four weeks or during the study period; cor pulmonale; facial deformity that causes
 air leakage; facial trauma and recent face or esophagus surgery; chest pain; hemoptysis in
 the last week; continued use of supplemental oxygen (> 8 hours / day); hemoptysis;
 hemodynamic instability and do not understand the use and command of the techniques used. The
 sample is selected by convenience from the database of individuals assisted data in
 Integrative Medicine Institute Professor Fernando Figueira (IMIP). The research will be
 developed in three phases, divided into three days with an interval of at least 48 hours
 between phases. The first day will undergo initial assessment and in the days following the
 intervention by day, ELTGOL or Acapella, in a randomized order.
Inclusion Criteria: Volunteers with Cystic Fibrosis and lung disease with chest
 hemiperímetro ≥ 37 cm. Exclusion Criteria: Episode of pulmonary infectious exacerbations in
 the last four weeks or during the study period; cor pulmonale; facial deformity that causes
 air leakage; facial trauma and recent face or esophagus surgery; chest pain; hemoptysis in
 the last week; continued use of supplemental oxygen (> 8 hours / day); hemoptysis;
 hemodynamic instability and do not understand the use and command of the techniques used.